… effects, as well. Taking into account its excellent safety profile and lack of clinically relevant
drug-drug interactions, the … , which contributes to the low-total incidence of adverse effects …

… that can lead to potential drug–drug interactions (DDIs). … of cardiovascular events in patients
with dyslipidemia. While … life-threatening side effects in real clinical settings. Cases ranging …

… of hypertension and dyslipidemia with antihypertensive … hypercholesterolemia in different
clinical settings was discussed … in case of the occurrence of adverse events with a first-line lipid-…

… 4010 patients from different clinical settings (34% from … Finally, since many patients with
dyslipidemia have other … the risk of drug–drug interactions and potential side effects. In this …

… The patient’s medical history included coronary artery disease and hyperlipidemia for which
… care and reduce the incidence of adverse effects. Transitions of care, management of drug …

… about RC is the drug-drug and drug-herb interactions. Co-… that is used clinically for the
treatment of hyperlipidemia. In the … the effect of the combination on the adverse effects of RC. …

… used anti-dyslipidemia agents that belongs to the statin class … hyperlipidemia are the two
types of hyperlipidemia: Primary … rate of adverse effects with rosuvastatin is comparable to that …

… Drug-associated adverse events can present with varying … She developed rosuvastatinassociated
adverse events, which … Her past medical history was significant for hyperlipidemia, …

… uncontrolled dyslipidemia attributable to heavy proteinuria. … In our case, the above drug-drug
interaction did not happen … -associated side effect and not a drug-drug interaction. Certainly, …

… Rosuvastatinassociated adverse effects and drug-drug interactions in the clinical setting of
dyslipidemia. Am J Cardiovasc Drug, 2010; 10(1):11–28. Küskü-Kiraz Z, Mehmetçik G, Dogru-…